Barclays’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Sell
1
-20,107
-100% ﹤0.01% 4617
2025
Q1
$65K Sell
20,108
-9,896
-33% -$32K ﹤0.01% 3826
2024
Q4
$119K Buy
30,004
+3,661
+14% +$14.5K ﹤0.01% 3757
2024
Q3
$204K Buy
26,343
+18,761
+247% +$145K ﹤0.01% 3457
2024
Q2
$39K Buy
+7,582
New +$39K ﹤0.01% 3769
2022
Q2
Sell
-2,563
Closed -$23K 4941
2022
Q1
$23K Sell
2,563
-15,921
-86% -$143K ﹤0.01% 4295
2021
Q4
$206K Buy
18,484
+12,220
+195% +$136K ﹤0.01% 2821
2021
Q3
$80K Buy
6,264
+4,256
+212% +$54.4K ﹤0.01% 3288
2021
Q2
$34K Sell
2,008
-10,228
-84% -$173K ﹤0.01% 3558
2021
Q1
$210K Buy
12,236
+7,424
+154% +$127K ﹤0.01% 3103
2020
Q4
$75K Sell
4,812
-1,783
-27% -$27.8K ﹤0.01% 3061
2020
Q3
$127K Sell
6,595
-1,300
-16% -$25K ﹤0.01% 2941
2020
Q2
$108K Buy
7,895
+2,636
+50% +$36.1K ﹤0.01% 3084
2020
Q1
$56K Sell
5,259
-13,807
-72% -$147K ﹤0.01% 3053
2019
Q4
$356K Buy
19,066
+3,161
+20% +$59K ﹤0.01% 2870
2019
Q3
$166K Buy
15,905
+1,728
+12% +$18K ﹤0.01% 3143
2019
Q2
$108K Sell
14,177
-65,375
-82% -$498K ﹤0.01% 3550
2019
Q1
$877K Buy
79,552
+79,544
+994,300% +$877K ﹤0.01% 2241
2018
Q4
$0 Hold
8
﹤0.01% 4428
2018
Q3
$0 Hold
8
﹤0.01% 4499
2018
Q2
$0 Sell
8
-4,110
-100% ﹤0.01% 4409
2018
Q1
$21K Buy
4,118
+17
+0.4% +$87 ﹤0.01% 3830
2017
Q4
$16K Buy
4,101
+3,348
+445% +$13.1K ﹤0.01% 3758
2017
Q3
$3K Buy
753
+367
+95% +$1.46K ﹤0.01% 3819
2017
Q2
$2K Sell
386
-782
-67% -$4.05K ﹤0.01% 3713
2017
Q1
$20K Sell
1,168
-1,056
-47% -$18.1K ﹤0.01% 3375
2016
Q4
$23K Buy
2,224
+2,019
+985% +$20.9K ﹤0.01% 3050
2016
Q3
$2K Sell
205
-2,494
-92% -$24.3K ﹤0.01% 3638
2016
Q2
$57K Buy
2,699
+2,384
+757% +$50.3K ﹤0.01% 2536
2016
Q1
$3K Sell
315
-359
-53% -$3.42K ﹤0.01% 3168
2015
Q4
$7K Buy
+674
New +$7K ﹤0.01% 2868